Venture capital investors showed biopharmaceutical start-ups and growth-stage private companies some love with a trio of $100m-plus financings announced on 14 and 16 February, including a $236m series
IN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Zephyrus Biosciences Inc. Bio-Techne acquired private research tools company Zephyrus Biosciences Inc. Zephyrus will be rolled up into Bi